Thursday, August 29, 2013

Sandoz Canada launches Salinex ProTectTM - A nasal spray product containing Iota-Crrageenan

Sandoz Canada announced today the launch in Canada of Salinex ProTectTM.
Salinex ProTectTM is a 20 mL nasal spray indicated for the early treatment of viral infections of the upper respiratory tract and the early treatment of common cold for both adults and children. 

As a non-pill alternative to fighting the common cold, Salinex ProTectTM works by creating a protective layer in the nasal cavity which helps reduce the spreading and proliferation of the common cold virus rather than medicinal absorption into the body. It provides symptomatic relief for nasal congestion and runny nose and helps to reduce the duration of cold symptoms by reducing viral load in nasal secretions when used at the onset of cold symptoms.

“Salinex ProTectTM is Canada’s first-to-market nasal spray product containing Iota-Carrageenan, which is derived from a red algae or seaweed and helps reduce the replication process of the virus. Clinical research has shown that this product provides relief against the common cold and upper respiratory tract viruses,” said Michel Robidoux, President and General Manager of Sandoz Canada. ”The launch of Salinex ProTectTM further expands our current line of Salinex nasal spray products which includes saline nasal sprays for adults and children, as well as pediatric drops.”
According to Health Canada, the common cold affects almost 4 million Canadians every year.












Enter your email address:


Delivered by FeedBurner